FBXO6
Basic information
Region (hg38): 1:11664200-11674354
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FBXO6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 24 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 4 | 1 |
Variants in FBXO6
This is a list of pathogenic ClinVar variants found in the FBXO6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-11668687-T-G | not specified | Uncertain significance (Oct 19, 2024) | ||
1-11668710-G-A | not specified | Uncertain significance (Nov 15, 2024) | ||
1-11668734-A-G | not specified | Uncertain significance (Jun 30, 2023) | ||
1-11668735-C-T | not specified | Uncertain significance (Feb 07, 2025) | ||
1-11668736-G-A | not specified | Likely benign (Apr 20, 2024) | ||
1-11668746-G-A | not specified | Uncertain significance (Feb 13, 2024) | ||
1-11668796-C-A | not specified | Uncertain significance (May 17, 2023) | ||
1-11668857-G-A | not specified | Uncertain significance (Nov 22, 2022) | ||
1-11668868-G-C | not specified | Uncertain significance (Mar 03, 2025) | ||
1-11668872-G-A | not specified | Uncertain significance (Apr 19, 2023) | ||
1-11668913-T-A | not specified | Uncertain significance (Dec 13, 2022) | ||
1-11668917-A-G | not specified | Uncertain significance (Jun 03, 2024) | ||
1-11668942-A-C | not specified | Uncertain significance (Oct 21, 2024) | ||
1-11671308-G-A | Benign (Aug 03, 2017) | |||
1-11671320-A-G | not specified | Uncertain significance (Dec 10, 2024) | ||
1-11671383-C-T | not specified | Uncertain significance (Feb 28, 2025) | ||
1-11671941-T-G | not specified | Uncertain significance (Jul 07, 2024) | ||
1-11671999-G-A | not specified | Uncertain significance (Jul 11, 2023) | ||
1-11671999-G-T | not specified | Uncertain significance (Apr 07, 2022) | ||
1-11672010-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
1-11673285-C-G | not specified | Uncertain significance (Oct 29, 2024) | ||
1-11673344-T-G | not specified | Uncertain significance (May 26, 2023) | ||
1-11673347-G-C | not specified | Uncertain significance (Nov 15, 2024) | ||
1-11673395-A-G | not specified | Likely benign (Mar 22, 2023) | ||
1-11673642-C-T | not specified | Uncertain significance (Feb 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FBXO6 | protein_coding | protein_coding | ENST00000376753 | 5 | 10231 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0152 | 0.961 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.251 | 190 | 181 | 1.05 | 0.0000113 | 1916 |
Missense in Polyphen | 61 | 68.378 | 0.89211 | 726 | ||
Synonymous | -0.179 | 79 | 77.0 | 1.03 | 0.00000497 | 575 |
Loss of Function | 1.97 | 5 | 12.5 | 0.400 | 6.22e-7 | 123 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000260 | 0.000260 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000969 | 0.0000967 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Substrate-recognition component of some SCF (SKP1-CUL1- F-box protein)-type E3 ubiquitin ligase complexes. Involved in endoplasmic reticulum-associated degradation pathway (ERAD) for misfolded lumenal proteins by recognizing and binding sugar chains on unfolded glycoproteins that are retrotranslocated into the cytosol and promoting their ubiquitination and subsequent degradation. Able to recognize and bind denatured glycoproteins, which are modified with not only high-mannose but also complex- type oligosaccharides. Also recognizes sulfated glycans. Also involved in DNA damage response by specifically recognizing activated CHEK1 (phosphorylated on 'Ser-345'), promoting its ubiquitination and degradation. Ubiquitination of CHEK1 is required to insure that activated CHEK1 does not accumulate as cells progress through S phase, or when replication forks encounter transient impediments during normal DNA replication. {ECO:0000269|PubMed:18203720, ECO:0000269|PubMed:19716789}.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;Chaperonin-mediated protein folding;Immune System;Association of TriC/CCT with target proteins during biosynthesis;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation;Protein folding
(Consensus)
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- loftool
- 0.862
- rvis_EVS
- 0.35
- rvis_percentile_EVS
- 74.49
Haploinsufficiency Scores
- pHI
- 0.140
- hipred
- N
- hipred_score
- 0.461
- ghis
- 0.473
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.654
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fbxo6
- Phenotype
Gene ontology
- Biological process
- DNA damage checkpoint;protein polyubiquitination;DNA repair;proteolysis;glycoprotein catabolic process;response to unfolded protein;ubiquitin-dependent ERAD pathway;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;post-translational protein modification
- Cellular component
- cytoplasm;cytosol;SCF ubiquitin ligase complex;endoplasmic reticulum quality control compartment
- Molecular function
- ubiquitin-protein transferase activity;protein binding;carbohydrate binding;ubiquitin protein ligase activity